Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
9.39M
-
Number of holders
-
90
-
Total 13F shares, excl. options
-
9.72M
-
Shares change
-
+470K
-
Total reported value, excl. options
-
$465M
-
Value change
-
+$39.2M
-
Number of buys
-
51
-
Number of sells
-
-25
-
Price
-
$47.89
Significant Holders of Korro Bio, Inc. - Common Stock (KRRO) as of Q3 2025
95 filings reported holding KRRO - Korro Bio, Inc. - Common Stock as of Q3 2025.
Korro Bio, Inc. - Common Stock (KRRO) has 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.72M shares
.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (1.14M shares), NEA Management Company, LLC (1.09M shares), Driehaus Capital Management LLC (672K shares), FMR LLC (564K shares), Point72 Asset Management, L.P. (532K shares), Cormorant Asset Management, LP (465K shares), BlackRock, Inc. (447K shares), Siren, L.L.C. (419K shares), TCG Crossover Management, LLC (416K shares), and VANGUARD GROUP INC (396K shares).
This table shows the top 90 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.